[{"address1": "1525 O\u2019Brien Drive", "city": "Menlo Park", "state": "CA", "zip": "94025", "country": "United States", "phone": "833-694-2553", "website": "https://grail.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.", "fullTimeEmployees": 1360, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert P. Ragusa", "age": 63, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 1478221, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joshua J. Ofman M.D., M.S.H.S", "age": 58, "title": "President", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 1036767, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Aaron  Freidin", "title": "Chief Financial Officer", "fiscalYear": 2023, "totalPay": 801324, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Ciccolella", "title": "Senior Vice President of Research, Development & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Abram  Barth J.D., M.P.H.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rodger  Currie", "title": "VP and Head of Government Affairs & Alliance Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng", "title": "President Biopharma Business & Europe", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Satnam  Alag Ph.D.", "title": "Senior VP of Software Engineering & Chief Security Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alice A. Chen", "title": "VP of Product & Head of Program Management Organization", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nathan  Hunkapiller Ph.D.", "title": "Senior VP of Research & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 19.41, "open": 19.25, "dayLow": 18.86, "dayHigh": 20.0586, "regularMarketPreviousClose": 19.41, "regularMarketOpen": 19.25, "regularMarketDayLow": 18.86, "regularMarketDayHigh": 20.0586, "volume": 363159, "regularMarketVolume": 363159, "averageVolume": 777953, "averageVolume10days": 1307810, "averageDailyVolume10Day": 1307810, "bid": 19.54, "ask": 19.72, "bidSize": 400, "askSize": 300, "marketCap": 658575680, "fiftyTwoWeekLow": 12.33, "fiftyTwoWeekHigh": 24.92, "priceToSalesTrailing12Months": 5.5968494, "fiftyDayAverage": 16.8706, "twoHundredDayAverage": 15.717753, "currency": "USD", "enterpriseValue": -172071296, "floatShares": 21619290, "sharesOutstanding": 33600800, "sharesShort": 3780404, "sharesShortPriorMonth": 3534327, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.1305, "heldPercentInsiders": 0.13751, "heldPercentInstitutions": 0.67057, "shortRatio": 6.73, "impliedSharesOutstanding": 33600800, "bookValue": 77.932, "priceToBook": 0.25150132, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -2117465984, "trailingEps": -58.29, "enterpriseToRevenue": -1.462, "enterpriseToEbitda": 0.265, "52WeekChange": 0.43484628, "SandP52WeekChange": 0.25891924, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "GRAL", "underlyingSymbol": "GRAL", "shortName": "GRAIL, Inc.", "longName": "GRAIL, Inc.", "firstTradeDateEpochUtc": 1718199000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "29546564-a6f8-352f-a054-8ba6790f8b80", "messageBoardId": "finmb_321823804", "gmtOffSetMilliseconds": -18000000, "currentPrice": 19.6, "targetHighPrice": 16.0, "targetLowPrice": 16.0, "targetMeanPrice": 16.0, "targetMedianPrice": 16.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 853550976, "totalCashPerShare": 25.706, "ebitda": -650012992, "totalDebt": 72191000, "quickRatio": 9.216, "currentRatio": 9.65, "totalRevenue": 117669000, "debtToEquity": 2.79, "revenuePerShare": 3.544, "operatingCashflow": -612563968, "revenueGrowth": 0.383, "grossMargins": -0.68586, "operatingMargins": -6.4046803, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-28"}]